We are live on
!
Find out more
KCM
Kingdon Capital Management Portfolio holdings
AUM
$911M
1-Year Est. Return
51.11%
This Fund
S&P 500
This Quarter
Est. Return
+2.1%
1 Year Est. Return
+51.11%
3 Year Est. Return
+185.44%
5 Year Est. Return
+284.29%
10 Year Est. Return
+2,022.7%
AUM
$2.23B
AUM Growth
-$381M
(-15%)
Cap. Flow
-$365M
Cap. Flow
% of AUM
-16.4%
Top 10 Holdings %
Top 10 Hldgs %
38.36%
Holding
222
New
46
Increased
40
Reduced
47
Closed
69
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coca-Cola Europacific Partners
CCEP
|
+$35.5M |
| 2 |
AGN
Allergan Inc
AGN
|
+$33M |
| 3 |
Brinker International
EAT
|
+$26.9M |
| 4 |
CBRE Group
CBRE
|
+$26.7M |
| 5 |
JKS
JinkoSolar
JKS
|
+$26.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Halliburton
HAL
|
+$58.6M |
| 2 |
Home Depot
HD
|
+$46.7M |
| 3 |
NRF
NorthStar Realty Finance Corp.
NRF
|
+$31.7M |
| 4 |
NFX
Newfield Exploration
NFX
|
+$23.5M |
| 5 |
Range Resources
RRC
|
+$23.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.39% |
| 2 | Technology | 9.23% |
| 3 | Consumer Staples | 7.82% |
| 4 | Energy | 5.85% |
| 5 | Consumer Discretionary | 5.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Fate Therapeutics
FATE
$300M
| $7.28M | 0.33% |
1,427,675
+230,000
| +19% | +$1.33M |
|
77
Radware
RDWR
$1.21B
| $7.16M | 0.32% |
405,000
| – | – |
|
78
Tempest Therapeutics
TPST
$14.2M
| $7.13M | 0.32% |
147
-12
| -8% | -$421K |
|
79
F5
FFIV
$23.4B
| $7.12M | 0.32% |
60,000
-135,000
| -69% | -$15.9M |
|
80
Monolithic Power Systems
MPWR
$65.6B
| $7.12M | 0.32% |
+161,666
| New | +$7.11M |
|
|
PLXP
81
DELISTED
PLx Pharma Inc. Common Stock
PLXP
| $6.97M | 0.31% |
88,750
| – | – |
|
|
BRCM
82
DELISTED
BROADCOM CORP CL-A
BRCM
| $6.95M | 0.31% |
+172,000
| New | +$6.68M |
|
|
ZLTQ
83
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $6.65M | 0.3% |
293,675
+6,000
| +2% | +$119K |
|
84
Kosmos Energy
KOS
$1.44B
| $6.47M | 0.29% |
650,000
+250,000
| +63% | +$2.5M |
|
|
BWLD
85
DELISTED
Buffalo Wild Wings, Inc.
BWLD
| $6.46M | 0.29% |
48,111
+17,111
| +55% | +$2.53M |
|
86
A.O. Smith
AOS
$8.61B
| $6.38M | 0.29% |
270,000
+70,000
| +35% | +$1.7M |
|
|
LEJU
87
DELISTED
Leju Holdings Limited American Depositary Shares, each representing ten (10) Ordinary Shares
LEJU
| $6.33M | 0.28% |
49,300
+6,800
| +16% | +$939K |
|
88
Tower Semiconductor
TSEM
$27.1B
| $6.3M | 0.28% |
+620,000
| New | +$6.58M |
|
|
FRC
89
DELISTED
First Republic Bank
FRC
| $6.17M | 0.28% |
+125,000
| New | +$6.12M |
|
|
GIMO
90
DELISTED
Gigamon Inc.
GIMO
| $6.11M | 0.27% |
583,390
| – | – |
|
91
Bloomin' Brands
BLMN
$764M
| $6.03M | 0.27% |
328,935
-363,706
| -53% | -$6.67M |
|
92
Chipotle Mexican Grill
CMG
$42.8B
| $6M | 0.27% |
450,000
-597,500
| -57% | -$7.83M |
|
|
CODE
93
DELISTED
SPANSION INC, CLASS A COMMON STOCK
CODE
| $5.86M | 0.26% |
256,900
-63,100
| -20% | -$1.34M |
|
|
KIN
94
DELISTED
Kindred Biosciences, Inc.
KIN
| $5.77M | 0.26% |
623,753
-120,750
| -16% | -$1.63M |
|
95
ScottsMiracle-Gro
SMG
$3.86B
| $5.74M | 0.26% |
104,368
-42,000
| -29% | -$2.36M |
|
96
CALL
Herc Holdings
HRI
$5.71B
| $5.71M | 0.26% |
75,000
+25,000
| +50% | +$2.14M |
|
97
Heron Therapeutics
HRTX
$96.8M
| $5.7M | 0.26% |
683,315
+45,000
| +7% | +$419K |
|
98
Starbucks
SBUX
$120B
| $5.48M | 0.25% |
145,318
-44,682
| -24% | -$1.73M |
|
99
CALL
MGIC Investment
MTG
$6.35B
| $5.47M | 0.25% |
+700,000
| New | +$5.73M |
|
100
Insmed
INSM
$21.4B
| $5.22M | 0.23% |
+400,000
| New | +$6.03M |
|
Similar funds
GC
ICP
NAM
SAA
GIG
SI
PAMI
BDP
Kingdon Capital Management's Q3 2014 Portfolio in Review
As of Q3 2014, Kingdon Capital Management held 222 positions worth $2.23B, down 15% from $2.61B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Kingdon Capital Management withdrew a net $365M in Q3 2014, closing 69 positions and reducing 47 holdings. Its most notable exit was Halliburton, an estimated $58.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 13% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Kingdon Capital Management opened a new position in Allergan Inc worth $35.4M.
- Kingdon Capital Management's largest Q3 2014 buy was Allergan Inc: 198,700 shares worth $35.4M.
- Kingdon Capital Management added most to Coca-Cola Europacific Partners in Q3 2014, an estimated $35.5M increase.
- Kingdon Capital Management's biggest Q3 2014 reduction was Home Depot, cutting an estimated $46.7M.
- Kingdon Capital Management fully exited Halliburton in Q3 2014, selling an estimated $58.6M.
- Kingdon Capital Management's ten largest holdings make up 38% of its $2.23B portfolio in Q3 2014.
- Kingdon Capital Management opened 46 new positions and closed 69 in Q3 2014.
- Kingdon Capital Management's portfolio value fell 15% quarter-over-quarter to $2.23B.
Based on Kingdon Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.